| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.046 | 0.3 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.3 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.3 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.045 | 0.3 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.3 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.3 |